Partner Series—Inflammation and Nutrition: Opportunities For A Growing Market

Available: On Demand
Speakers: Ram Chaudhari, Ph.D., FACN, CNS, Sr. Executive VP, Chief Scientific Officer & Co-Founder, Fortitech; Christopher P. Cannon, MD, Senior Investigator, TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Associate Professor of Medicine, Harvard Medical School

INSIDER Partner Series

An important development in nutritional science in recent years has been the discovery of anti-inflammatory properties of certain nutrients and bioactive food components.  There has also been the rediscovery and increased appreciation of the potential value of certain herbs, spices and other botanical-based traditional medicine approaches that may fight inflammation and help in the prevention or treatment of certain diseases or conditions.  The general public is less aware of the importance of dietary anti-inflammatory nutrients than they should be, but there has been a growing awareness of this concept among the more health-conscious consumer.  The latter group has likely gained this awareness from the many positive news reports of the health benefits associated with fish consumption and the role of omega-3 fatty acids, such as DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) in reducing inflammation.  It is important that this consumer momentum and awareness about anti-inflammatory nutrients is capitalized upon and expanded.

This Webinar will demonstrate how strategic nutrition can be employed to develop novel fortified food and beverage products targeted at reducing or managing inflammation.  Attendees will learn about specific anti-inflammatory nutrients and bioactive components, formulation challenges and solutions and gain an overview of custom nutrient premix prototypes developed for specific product applications.

Speakers:

Ram Chaudhari
In 1986, Dr. Chaudhari co-founded Fortitech, the only international company exclusively dedicated to the manufacture of custom designed premixes. Dr. Chaudhari spearheads the company’s extensive research and development and quality assurance efforts. He is responsible for directing Fortitech’s global team of technical, laboratory and quality control personnel that help manufacturers develop new products, meet desired label claims, overcome formulation challenges and address processing requirements. He oversees the rigorous testing standards of each Fortitech nutrient premix to ensure potency and consistency. Under his leadership, the quality of Fortitech’s technical support helped position Fortitech as the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries. Today, Fortitech’s custom nutrient premixes are used to fortify a wide range of products, including baby formulas, cereals, nutrition bars, dairy products, sports drinks, juices, waters, snacks, candies, supplements and more. Dr. Chaudhari received his bachelor’s degree in agriculture from the Agriculture Institute Gujarat in India. He later attended Utah State University in Logan, Utah, where he received his master’s and doctorate degrees in nutrition and food science. He is a member of a number of professional organizations, including Institute of Food Technologists (IFT), American Association of Cereal Chemists, World Trade Centers Association and American Oil Chemists Society. He is also a charter member of the National Health and Wellness Association and a certified member of the American College of Nutrition. Dr. Chaudhari is also active with the Global Alliance for Improved Nutrition (GAIN), World Health Organization (WHO), the Synergos Institute, the Clinton Global Initiative (CGI) and he serves on the editorial advisory board for Agro Food Industry hi-tech based in Milan, Italy.



Christopher CannonDr. Cannon is a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, leading trials such as TACTICS-TIMI 18, PROVE IT-TIMI 22, and CLARITY-TIMI 28. He earned his MD from Columbia University College of Physicians and Surgeons in New York, and after completing his residency in internal medicine at Columbia Presbyterian Medical Center, he was a cardiovascular fellow at Brigham and Women’s Hospital. Dr. Cannon has published over 900 original articles, reviews, book chapters or electronic publications on the topic of acute coronary syndromes, including works in Circulation, Journal of the American College of Cardiology, Lancet, and the New England Journal of Medicine.  He has received numerous awards, including the Alfred Steiner Research Award, and the Upjohn Achievement in Research Award, and leadership awards from the ACC and AHA. He is editor-in-chief of the ACC’s website, Cardiosource (www.cardiosource.com) as well as the journal Critical Pathways in Cardiology and a 60-book series Contemporary Cardiology. He has authored or edited 10 books, including the New Heart Disease Handbook for patients.


Content developed and sponsored by:

FORTITECH